Topas Therapeutics
GermanyEntry
2017
Hold
9yr
Status
Active
Who owns Topas Therapeutics?
Topas Therapeutics is a German Biotech company, currently owned by Boehringer Ingelheim Venture Fund since 2017 and Gimv.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Most recent investor
Boehringer Ingelheim Venture FundBoehringer Ingelheim Venture Fund · 2010 · Evergreen
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods
Active
GimvActive
present · Gimv Portfolio
More from Boehringer Ingelheim Venture Fund
Other portfolio companies in the same fund.
US
SwitzerlandMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Topas Therapeutics?
Topas Therapeutics is currently owned by Boehringer Ingelheim Venture Fund and Gimv, through Boehringer Ingelheim Venture Fund, since 2017.
When did Boehringer Ingelheim Venture Fund and 1 other acquire Topas Therapeutics?
Boehringer Ingelheim Venture Fund and 1 other acquired Topas Therapeutics in 2017.
Who has owned Topas Therapeutics over time?
Topas Therapeutics has been through 2 private-equity ownership periods: Boehringer Ingelheim Venture Fund · via Boehringer Ingelheim Venture Fund · since 2017; Gimv.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue